Vitamin E Supplementation and Plasma 8‐Isoprostane and Adiponectin in Overweight Subjects
Authors:
- Wayne H. F. SutherlandWSWayne H. F. Sutherland
- Sylvia A. De JongSJSylvia A. De Jong
Abstract
Objective: Isoprostanes are a marker of oxidant stress and atherosclerotic risk, and plasma concentrations are elevated in obesity. Adiponectin is a regulator of insulin sensitivity, and low circulating levels are associated with oxidant stress and obesity. The aim of this study was to determine the effect of vitamin E supplementation on plasma concentrations of 8‐isoprostane and adiponectin in overweight/obese subjects.Research Methods and Procedures: The study was a 6‐month, randomized, double‐blind, placebo‐controlled trial in 80 overweight subjects (60 women and 20 men, BMI >27 kg/m2). Exclusion criteria were serious illness, smoking, or taking antioxidant supplements. Participants were randomized to receive 800 IU/d natural vitamin E (n = 39) or placebo (n = 41) for 3 months with an increase in the dose to 1200 IU/d for a further 3 months. Plasma 8‐isoprostane and adiponectin concentrations were measured at baseline and 3 and 6 months.Results: During 6 months of supplementation with vitamin E, plasma vitamin E concentration increased significantly (p < 0.001) by 76%, and plasma 8‐isoprostane concentrations decreased significantly (−11%, p = 0.03), whereas plasma adiponectin concentrations did not change significantly.Discussion: These findings suggest that supplementation with high‐dose vitamin E decreases systemic oxidative stress and 8‐isoprostane concentrations in overweight/obese individuals. A decrease in plasma 8‐isoprostane has the potential to reduce risk of cardiovascular disease in obesity.Keywords
This publication has 43 references indexed in Scilit:
- Oxidative Stress and Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Plasma F2-Isoprostanes and Coronary Artery Calcification: The CARDIA StudyClinical Chemistry, 2005
- Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-α transgenic mouse model of liver cancerJournal of Hepatology, 2004
- 8‐isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP‐1 macrophages, resulting in long‐lived foam cellsEuropean Journal of Clinical Investigation, 2004
- Obesity and Systemic Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Editorial reasonable engineering guessIEEE Transactions on Reliability, 2003
- The F2-Isoprostane 8-Epiprostaglandin F2αIncreases Platelet Adhesion and Reduces the Antiadhesive and Antiaggregatory Effects of NOArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- In Vivo Formation of 8-Epi-Prostaglandin F2αIs Increased in HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- AdipoQ Is a Novel Adipose-specific Gene Dysregulated in ObesityJournal of Biological Chemistry, 1996
- Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.Journal of Clinical Investigation, 1992